Acute Intermittent Porphyria Market: Industry Analysis, Epidemiology, Pipeline Therapies, Companies and Forecast by DelveInsight
Acute Intermittent Porphyria is a genetic metabolic disorder. It affects the production of heme, the oxygen-binding prosthetic group of hemoglobin. Generally, it is characterized by a deficiency of the enzyme porphobilinogen deaminase.
DelveInsight's "Acute
Intermittent Porphyria Market Insights, Epidemiology, and Market
Forecast-2030" report delivers an in-depth understanding of the
Acute Intermittent Porphyria, historical and forecasted epidemiology as well as
the Acute Intermittent Porphyria market trends in the United States, EU5
(Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key facts of Acute
Intermittent Porphyria Market are:
·
According to the WHO estimates, neurological
disorders are responsible for 4.5%-11% of all illnesses including low or high
income economies.
·
According to the American Liver Foundation,
there is an increasing the prevalence of liver disease in the U.S. from then
last few years. It further stated that at least 30 million people have some
form of liver disease.
·
The growing awareness about porphyria and growth
of the healthcare sector in emerging countries are the major drivers for the
acute intermittent porphyria market.
·
The United States holds the highest Acute
Intermittent Porphyria market share in 7MM.
View Report: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/acute-intermittent-porphyria-market
Scope of Acute
Intermittent Porphyria Market Report:
- The report covers the descriptive
overview of Acute Intermittent Porphyria, explaining its causes, signs and
symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided
into the Acute Intermittent Porphyria epidemiology and treatment in the
7MM
- Additionally, an all-inclusive account
of both the current and emerging therapies for Acute Intermittent
Porphyria are provided, along with the assessment of new therapies, which
will have an impact on the current treatment landscape
- A detailed review of Acute Intermittent
Porphyria market; historical and forecasted is included in the report,
covering drug outreach in the 7MM
- The report provides an edge while
developing business strategies, by understanding trends shaping and
driving the global Acute Intermittent Porphyria market
Acute
Intermittent Porphyria Companies are:
·
Dahaner
·
F.
Hoffmann-La Roche Ltd
·
Bio-Rad
Laboratories, Inc.
·
Siemens
AG
·
ARKRAY,
Inc.
·
Sysmex
Corporation
·
ACON
Laboratories, Inc.
·
Alnylam
Pharmaceuticals
·
Digna
Biotech S.L
- Zymenex A/S
- Chiesi Farmaceutici S.p.A.
- And Many More
View Report: https://www.delveinsight.com/report-store/acute-intermittent-porphyria-market
Get a Sample Report: https://www.delveinsight.com/sample-request/acute-intermittent-porphyria-market
Acute
Intermittent Porphyria Therapies are:
·
Givosiran
·
recombinant human porphobilinogen deaminase
(Porphozym)
·
ALN-AS1
·
And Many More
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/acute-intermittent-porphyria-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Acute Intermittent Porphyria
3. Competitive
Intelligence Analysis for Acute Intermittent Porphyria
4. Acute
Intermittent Porphyria: Market Overview at a Glance
5. Acute
Intermittent Porphyria: Disease Background and Overview
6. Patient Journey
7. Acute
Intermittent Porphyria Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of
Acute Intermittent Porphyria Treatment
11. Marketed
Products
List to be continued
in report
12. Emerging
Therapies
List to be continued
in report
13. Acute
Intermittent Porphyria: Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and Reimbursement
Overview of Acute Intermittent Porphyria
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
23. About
DelveInsight
Some of Newly Launched Report:
·
Neuromodulation
Devices market
·
Neurostimulation
Devices market
·
Hernia
repair devices market
About Delveinsight:
DelveInsight Business Research is a leading Market
Research, and Business Consultant focused purely on Healthcare. It
helps pharma companies by providing them with end-to-end services to solve
their business problems.
Get hold of all the Pharma and healthcare market research
reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business
Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment